CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity. 会议论文
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-01-20
作者:  Gong, Jifang;  Liu, Tianshu;  Fan, Qingxia;  Bai, Li;  Bi, Feng
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace